98 related articles for article (PubMed ID: 16061859)
1. A predictive model of rectal tumor response to preoperative radiotherapy using classification and regression tree methods.
Zlobec I; Steele R; Nigam N; Compton CC
Clin Cancer Res; 2005 Aug; 11(15):5440-3. PubMed ID: 16061859
[TBL] [Abstract][Full Text] [Related]
2. The predictive value of apoptosis protease-activating factor 1 in rectal tumors treated with preoperative, high-dose-rate brachytherapy.
Zlobec I; Vuong T; Compton CC
Cancer; 2006 Jan; 106(2):284-6. PubMed ID: 16315248
[TBL] [Abstract][Full Text] [Related]
3. VEGF as a predictive marker of rectal tumor response to preoperative radiotherapy.
Zlobec I; Steele R; Compton CC
Cancer; 2005 Dec; 104(11):2517-21. PubMed ID: 16222693
[TBL] [Abstract][Full Text] [Related]
4. The use of molecular markers as a method to predict the response to neoadjuvant therapy for advanced stage rectal adenocarcinoma.
Edden Y; Wexner SD; Berho M
Colorectal Dis; 2012 May; 14(5):555-61. PubMed ID: 21689364
[TBL] [Abstract][Full Text] [Related]
5. Prognostic and predictive value of baseline and posttreatment molecular marker expression in locally advanced rectal cancer treated with neoadjuvant chemoradiotherapy.
Bertolini F; Bengala C; Losi L; Pagano M; Iachetta F; Dealis C; Jovic G; Depenni R; Zironi S; Falchi AM; Luppi G; Conte PF
Int J Radiat Oncol Biol Phys; 2007 Aug; 68(5):1455-61. PubMed ID: 17445998
[TBL] [Abstract][Full Text] [Related]
6. Prognostic significance of vascular endothelial growth factor and cyclooxygenase-2 in patients with rectal cancer treated with preoperative radiotherapy.
Giralt J; Navalpotro B; Hermosilla E; de Torres I; Espin E; Reyes V; Cerezo L; de las Heras M; Ramon y Cajal S; Armengol M; Benavente S
Oncology; 2006; 71(5-6):312-9. PubMed ID: 17687192
[TBL] [Abstract][Full Text] [Related]
7. Molecular prognostic factors in locally irresectable rectal cancer treated preoperatively by chemo-radiotherapy.
Reerink O; Karrenbeld A; Plukker JT; Verschueren RC; Szabó BG; Sluiter WJ; Hospers GA; Mulder NH
Anticancer Res; 2004; 24(2C):1217-21. PubMed ID: 15154650
[TBL] [Abstract][Full Text] [Related]
8. Molecular markers and prediction of response to chemoradiation in rectal cancer.
Okonkwo A; Musunuri S; Talamonti M; Benson A; Small W; Stryker SJ; Rao MS
Oncol Rep; 2001; 8(3):497-500. PubMed ID: 11295069
[TBL] [Abstract][Full Text] [Related]
9. Bax, a predictive marker for therapeutic response to preoperative chemoradiotherapy in patients with rectal carcinoma.
Chang HJ; Jung KH; Kim DY; Jeong SY; Choi HS; Kim YH; Sohn DK; Yoo BC; Lim SB; Kim DH; Ahn JB; Kim IJ; Kim JM; Yoon WH; Park JG
Hum Pathol; 2005 Apr; 36(4):364-71. PubMed ID: 15891997
[TBL] [Abstract][Full Text] [Related]
10. Predictors of response to chemo-radiotherapy and radiotherapy for esophageal squamous cell carcinoma.
Miyazaki T; Kato H; Faried A; Sohda M; Nakajima M; Fukai Y; Masuda N; Manda R; Fukuchi M; Ojima H; Tsukada K; Kuwano H
Anticancer Res; 2005; 25(4):2749-55. PubMed ID: 16080521
[TBL] [Abstract][Full Text] [Related]
11. Mcl-1, vascular endothelial growth factor-R2, and 14-3-3sigma expression might predict primary response against radiotherapy and chemotherapy in patients with locally advanced squamous cell carcinomas of the head and neck.
Erovic BM; Pelzmann M; Grasl MCh; Pammer J; Kornek G; Brannath W; Selzer E; Thurnher D
Clin Cancer Res; 2005 Dec; 11(24 Pt 1):8632-6. PubMed ID: 16361547
[TBL] [Abstract][Full Text] [Related]
12. Molecular marker profiles predict locoregional control of head and neck squamous cell carcinoma in a randomized trial of continuous hyperfractionated accelerated radiotherapy.
Buffa FM; Bentzen SM; Daley FM; Dische S; Saunders MI; Richman PI; Wilson GD
Clin Cancer Res; 2004 Jun; 10(11):3745-54. PubMed ID: 15173081
[TBL] [Abstract][Full Text] [Related]
13. Ki-67, p53 and bcl-2 analysis in colonic versus rectal adenocarcinoma.
Petrişor O; Giuşcă SE; Sajin M; Dobrescu G; Căruntu ID
Rom J Morphol Embryol; 2008; 49(2):163-71. PubMed ID: 18516322
[TBL] [Abstract][Full Text] [Related]
14. Combined analysis of VEGF and EGFR predicts complete tumour response in rectal cancer treated with preoperative radiotherapy.
Zlobec I; Vuong T; Compton CC; Lugli A; Michel RP; Hayashi S; Jass JR
Br J Cancer; 2008 Jan; 98(2):450-6. PubMed ID: 18182986
[TBL] [Abstract][Full Text] [Related]
15. Predictive biological markers for response of invasive breast cancer to anthracycline/cyclophosphamide-based primary (radio-)chemotherapy.
Prisack HB; Karreman C; Modlich O; Audretsch W; Danae M; Rezai M; Bojar H
Anticancer Res; 2005; 25(6C):4615-21. PubMed ID: 16334152
[TBL] [Abstract][Full Text] [Related]
16. [Smac as a predictive marker of tumor response to preoperative radiotherapy in rectal cancer].
Pan ZZ; Lin JZ; Wan DS
Ai Zheng; 2008 Feb; 27(2):178-82. PubMed ID: 18279617
[TBL] [Abstract][Full Text] [Related]
17. Comparison of the prognostic value of a panel of tissue tumor markers and established clinicopathological factors in patients with gastric cancer.
Wiksten JP; Lundin J; Nordling S; Kokkola A; Haglund C
Anticancer Res; 2008; 28(4C):2279-87. PubMed ID: 18751407
[TBL] [Abstract][Full Text] [Related]
18. Cyclooxygenase-2 expression in pretreatment biopsy as a predictor of tumor responses after preoperative chemoradiation in rectal cancer.
Min BS; Choi YJ; Pyo HR; Kim H; Seong J; Chung HC; Rha SY; Kim NK
Arch Surg; 2008 Nov; 143(11):1091-7; discussion 1097. PubMed ID: 19015468
[TBL] [Abstract][Full Text] [Related]
19. Does preoperative chemo-radiotherapy enhance the expression of vascular endothelial growth factor in patients with rectal cancer?
Inoue Y; Ojima E; Watanabe H; Hiro J; Toiyama Y; Kobayashi M; Miki C; Kusunoki M
Oncol Rep; 2007 Aug; 18(2):369-75. PubMed ID: 17611658
[TBL] [Abstract][Full Text] [Related]
20. Prognostic and predictive effects of immunohistochemical factors in high-risk primary breast cancer patients.
Kröger N; Milde-Langosch K; Riethdorf S; Schmoor C; Schumacher M; Zander AR; Löning T
Clin Cancer Res; 2006 Jan; 12(1):159-68. PubMed ID: 16397038
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
